Could a Mediterranean-Ketogenic diet protect the gut in Parkinson's?
NCT ID NCT05469997
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a modified Mediterranean-ketogenic diet in 52 people with Parkinson's disease to see if it is safe for their gut microbiome. The diet limits carbs and emphasizes healthy fats and lean proteins. Researchers measured gut inflammation and other markers to check for any harm, aiming to find a diet that supports gut health without causing problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mediterranean-Ketogenic Diet
What this could lead to
If successful, this diet could offer a safe way for Parkinson's patients to manage gut symptoms without disrupting their gut microbiome.
What could go wrong
This is a small, completed safety study with only 52 participants, so results may not apply to everyone. Dietary changes can be hard to maintain and may not improve Parkinson's symptoms directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Djawad Mowafaghian Centre for Brain Health
Vancouver, British Columbia, V6T 1Z3, Canada